BTG Plc - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for BTG Plc. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

BTG Plc. The Group's principal activity developing and commercialising life science technologies. The Group in-licenses, develops and commercialises pharmaceuticals and has a broad pipeline of development programme targeting neurological and other disorders including varicose veins. It acquires the rights to early-stage pharmaceuticals and other medical technologies from a global network of corporations, universities and research institutions. The drug development programme are in the field of oncology, ageing, neuroscience and drug repositioning. The Group's products are Varisolve, Misopess, Benefix, Campath, Infecton, Juvidex and Symadex.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report